GLP-1 receptor agonists such as semaglutide and tirzepatide help people lose significant body weight, but a meaningful share of that loss can come from lean muscle mass rather than fat alone. Resistance training and adequate protein intake are the two most reliable tools for helping clients preserve muscle while losing weight on these medications. Trainers can play a valuable supporting role by programming strength work, reinforcing protein habits, and monitoring energy and performance, all while staying within scope of practice and deferring medical decisions to the client's prescribing clinician.
GLP-1 medications have moved from a niche diabetes treatment to one of the most talked-about tools in weight management, and that shift is reshaping the conversations trainers have with clients. More people than ever are walking into gyms and coaching sessions while taking a GLP-1 drug, and many of them have questions their prescriber did not have time to answer fully. What should they eat? Should they still lift? Why do they feel weaker some days? As a coach, you are not there to prescribe, adjust, or comment on the medication itself, but you are perfectly positioned to help clients protect their muscle, train effectively, and get the most out of the fat loss these drugs can produce. This guide walks through what the current evidence says and how to translate it into safe, in-scope coaching.
What GLP-1 Medications Actually Do
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals the pancreas to release insulin, slows how quickly the stomach empties, and acts on appetite centers in the brain to increase feelings of fullness. GLP-1 receptor agonists are medications that mimic this hormone at a higher and more sustained level than the body produces on its own.
The two names most clients will mention are semaglutide, sold under brand names including Ozempic and Wegovy, and tirzepatide, sold as Mounjaro and Zepbound. Tirzepatide is technically a dual agonist that also targets a second gut hormone receptor called GIP, but for coaching purposes both work primarily by reducing appetite and food intake. Please note that indications, brand names, and approval status vary (for example, semaglutide was first approved as Ozempic for type 2 diabetes in 2017 and as Wegovy for chronic weight management in 2021, and tirzepatide was approved as Mounjaro for type 2 diabetes in 2022 and as Zepbound for weight management in 2023), so never state a client's specific drug status as fact. Confirm nothing about their prescription; simply listen to what they share.
The headline effect is real and well documented in large randomized controlled trials: clients on these medications tend to lose substantial total body weight. In the STEP (semaglutide) trials, average reductions ranged from about 9.6 to 16.0 percent of body weight, and the SURMOUNT (tirzepatide) trials reported reductions of up to about 20.9 percent. The appetite suppression is often dramatic, which sets up the central coaching challenge this article addresses.
The Muscle-Loss Concern
Here is the issue that should shape everything a trainer does with a GLP-1 client. When anyone loses weight through an energy deficit, the weight that comes off is a mix of fat mass and lean mass, which includes muscle. This is true of any diet, not just medication-driven loss. The concern with GLP-1 drugs is that the appetite suppression can be so strong that clients eat far less overall, including far less protein, while also becoming more sedentary because they simply feel less driven to move and eat.
Body-composition analyses from GLP-1 trials suggest that a notable portion of the total weight lost can be lean mass rather than fat. In randomized controlled trials, lean mass has accounted for roughly 25 to 39 percent of the total weight lost on GLP-1 therapy. Losing some lean mass alongside fat is normal during weight loss, and a person carrying excess weight also carries some extra muscle to support that mass. The problem is when lean-mass loss is larger than it needs to be, because muscle drives metabolic rate, strength, function, and long-term weight maintenance. For older clients this matters even more, since muscle is already harder to hold onto with age. Adults can lose roughly 30 to 50 percent of their skeletal muscle mass between the ages of 40 and 80, and strength tends to decline even faster than mass.
The takeaway is not that GLP-1 medications are bad. It is that the fat-loss benefit is best protected by pairing the medication with the two interventions that have the strongest evidence base for preserving muscle: resistance training and adequate protein.
Why This Is a Coaching Opportunity, Not a Red Flag
Clients often assume the medication does all the work. Your job is to reframe that. The medication creates the deficit; training and nutrition determine the quality of the weight that is lost. That framing keeps clients engaged and keeps your role clearly defined and valuable.
Why Resistance Training Matters Most
If a client on a GLP-1 medication can only commit to one form of exercise, resistance training is the highest-priority choice. Progressive resistance training is the most reliable stimulus we have for signaling the body to retain, and in some cases build, muscle tissue even during an energy deficit. Cardio has real health benefits and supports overall energy balance, but it does not send the same muscle-preservation signal.
Practical programming does not need to be exotic. Aim to have clients train each major muscle group two to three days per week using compound movements they can perform safely, in line with ACSM guidance, with weekly set volume adjusted to the client's goal. Squat and hinge patterns, pushing, pulling, and loaded carries cover the essentials. The goal is meaningful mechanical tension applied consistently, with gradual progression in load or reps over time.
Coaching Cues for GLP-1 Clients
- Prioritize compound lifts first in the session, while energy is highest.
- Emphasize controlled tempo and full range of motion over chasing heavy singles, especially early on.
- Progress conservatively. Because these clients may be under-fueled, recovery capacity can be reduced.
- Track strength over time as a proxy for muscle retention. Holding or gaining strength during weight loss is a strong sign.
Common Mistakes to Avoid
- Defaulting to endless cardio because the client wants the scale to move faster. This can accelerate muscle loss.
- Programming high-volume, high-fatigue sessions that a low-appetite, low-energy client cannot recover from.
- Ignoring warning signs like dizziness or lightheadedness, which can relate to low food or fluid intake. When these appear, refer the client back to their clinician.
Why Protein Matters So Much
Protein is the nutritional partner to resistance training, and it is exactly where GLP-1 medications create friction. Reduced appetite means clients often struggle to eat enough total food, and protein, being filling, is frequently the first thing to fall short. Yet adequate protein is essential for muscle protein synthesis, the process that lets the body maintain and repair muscle tissue.
During an energy deficit, protein needs are generally higher than at weight maintenance to help protect lean mass. Around 1.2 to 1.7 grams per kilogram of body weight is usually enough for recreational exercisers during mild energy restriction, while leaner or resistance-trained clients who are cutting more aggressively often need more. For a client eating far less overall, hitting a protein target requires intention rather than appetite. This is squarely within a certified nutrition coach's scope: helping clients plan meals, build habits, and choose foods that meet their targets.
Practical Protein Strategies
- Anchor every meal and snack around a protein source first, then add other foods as appetite allows.
- Front-load protein earlier in the day, since many clients report appetite fades further as the day goes on.
- Use easy-to-consume options like Greek yogurt, eggs, poultry, fish, tofu, or a quality protein supplement when whole-food volume feels overwhelming.
- Spread protein across the day rather than concentrating it in one meal, which supports steady muscle protein synthesis.
Remember that general nutrition education and habit coaching are in scope. Prescribing a specific therapeutic diet to treat a medical condition, or advising on how food should interact with a client's medication dosing, is not. When a client asks how their eating should change around dose timing or side effects, direct them to their prescribing clinician or a registered dietitian.
Managing Side Effects Within Scope
Gastrointestinal side effects such as nausea, reduced appetite, and digestive discomfort are commonly reported by GLP-1 users, affecting roughly 40 to 70 percent of patients, and up to about 85 percent in some clinical reports. These can directly affect training. A nauseated, under-fueled client will not perform or recover well.
As a trainer you can adapt the plan around how the client feels on a given day, encourage hydration, and keep sessions productive but tolerable. What you must not do is interpret side effects, suggest the client change or skip a dose, or reassure them that a symptom is nothing to worry about. Persistent or severe symptoms are a medical matter. Your safe, professional response is to acknowledge what the client reports and encourage them to raise it with their healthcare provider.
Who This Approach Is Best For
The resistance-training-plus-protein framework applies to essentially every client on a GLP-1 medication who is cleared for exercise, but it is especially important for:
- Older adults, who are at higher risk of losing functional muscle.
- Clients who were largely sedentary before starting the medication.
- Anyone whose primary goal includes maintaining strength, mobility, or athletic performance while losing weight.
- Clients focused on long-term maintenance, since preserved muscle supports a higher resting metabolic rate and makes weight regain less likely.
Staying in Your Lane: Scope of Practice and Not Medical Advice
This section is not a disclaimer to skim. It is the foundation of doing this work responsibly. Personal trainers and nutrition coaches are not licensed to prescribe, adjust, monitor, or advise on medications, and GLP-1 drugs are prescription medications with real medical considerations. Your role is exercise programming, general nutrition coaching, behavior change, and accountability.
Stay in scope by doing the following. Ask clients to obtain medical clearance for exercise. Coach training and general nutrition, not pharmacology. Refer any medication questions, side-effect concerns, or symptoms back to the prescribing clinician or an appropriate licensed professional. Document referrals and clearances. Never position yourself as the client's authority on the drug itself.
Handled this way, GLP-1 medications are not a threat to your value as a coach. They expand it. These clients need exactly what a good trainer provides: a structured way to preserve muscle, a plan to eat enough protein, and a knowledgeable partner who keeps them accountable while respecting the boundaries of medical care.
If you want to deepen the nutrition expertise that makes you genuinely useful to clients on weight-loss medications, consider becoming an ISSA Certified Nutrition Coach. It gives you the evidence-based foundation to coach protein, energy balance, and habit change with confidence, all while staying firmly within scope.
This article is for educational purposes only and is not medical advice. Trainers should work within their scope of practice and refer clients to qualified healthcare providers for any medical or medication-related questions.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), overview of GLP-1 based therapies and how they work. https://www.niddk.nih.gov
- U.S. Food and Drug Administration (FDA), approved prescribing information for semaglutide and tirzepatide products. https://www.fda.gov
- American College of Sports Medicine (ACSM), resistance training and exercise prescription guidelines. https://www.acsm.org
- New England Journal of Medicine, STEP and SURMOUNT clinical trial reports on semaglutide and tirzepatide for weight management. https://www.nejm.org
- Academy of Nutrition and Dietetics, guidance on protein needs during weight loss. https://www.eatright.org
- International Society of Sports Nutrition (ISSN), position stand on protein and exercise. https://jissn.biomedcentral.com
